|
|
| | (Lys(Ac)5.8.12.16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) Basic information |
| Product Name: | (Lys(Ac)5.8.12.16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) | | Synonyms: | (Lys(Ac)5.8.12.16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl);L-Lysine, L-serylglycyl-L-arginylglycyl-N6-acetyl-L-lysylglycylglycyl-N6-acetyl-L-lysylglycyl-L-leucylglycyl-N6-acetyl-L-lysylglycylglycyl-L-alanyl-N6-acetyl-L-lysyl-L-arginyl-L-histidyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-arginyl-L-α-aspartyl-L-asparaginylglycyl-L-serylglycyl-L-seryl-N6-[5-[(3aS,4...;(Lys(Ac)?·?·??·??)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) trifluoroacetate salt;L-Lysine, L-serylglycyl-L-arginylglycyl-N6-acetyl-L-lysylglycylglycyl-N6-acetyl-L-lysylglycyl-L-leucylglycyl-N6-acetyl-L-lysylglycylglycyl-L-alanyl-N6-acetyl-L-lysyl-L-arginyl-L-histidyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-arginyl-L-α-aspartyl-L-asparaginylglycyl-L-serylglycyl-L-seryl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-;H-Ser-Gly-Arg-Gly-Lys(Ac)-Gly-Gly-Lys(Ac)-Gly-Leu- | | CAS: | 2022956-65-4 | | MF: | C141H243N53O43S | | MW: | 3400.84 | | EINECS: | | | Product Categories: | | | Mol File: | 2022956-65-4.mol |  |
| | (Lys(Ac)5.8.12.16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) Chemical Properties |
| density | 1.51±0.1 g/cm3(Predicted) | | Sequence | Ser-Gly-Arg-Gly-{Lys(Ac)}-Gly-Gly-{Lys(Ac)}-Gly-Leu-Gly-{Lys(Ac)}-Gly-Gly-Ala-{Lys(Ac)}-Arg-His-Arg-Lys-Val-Leu-Arg-Asp-Asn-Gly-Ser-Gly-Ser-{Lys(Biotinyl)} |
| | (Lys(Ac)5.8.12.16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) Usage And Synthesis |
| Uses | (Lys(Ac)5,8,12,16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development[1]. | | References | [1] Birnbaum S, et al. Peptide screening. Current Opinion in Biotechnology, 1992, 3(1): 49-54. |
| | (Lys(Ac)5.8.12.16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) Preparation Products And Raw materials |
|